stars 1 stars 2 stars 3

CellSight Diagnosis is a forward-thinking company founded by a dynamic team, including professionals from the fields of dentistry and oncology. The goal is to revolutionize leukemia diagnosis through advanced technology and comprehensive medical knowledge. They propose an innovative product that leverages artificial intelligence and image processing to enable early, accurate, and rapid diagnosis of acute leukemia. This software platform utilizes deep neural custom models to distinguish immature leukemic blasts from normal cells, facilitating precise diagnosis through microscopic image analysis. With a commitment to bridging the diagnostic gap and improving patient outcomes, CellSight Diagnosis is at the forefront of medical innovation, uniting expertise from diverse domains for a common purpose.

CellSight Diagnosis Questions

Ardeshir Malekian is the CEO of CellSight Diagnosis.

3 people are employed at CellSight Diagnosis.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users